[Effect of olivomycin and bruneomycin and their combined use with prodigiozan on some nonspecific defense reactions of the host organism of transplanted lymphadenosis NK-LI].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003864:Depression, Chemical; D004357:Drug Synergism; D007962:Leukocytes / Q000187:drug effects; D008223:Lymphoma / Q000188:drug therapy; D051379:Mice; D012157:Mononuclear Phagocyte System / Q000166:cytology* / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009848:Olivomycins / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D010529:Peritoneal Cavity / Q000166:cytology; D010587:Phagocytosis / Q000187:drug effects*; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage* / Q000627:therapeutic use; D012706:Serratia marcescens; D013268:Stimulation, Chemical
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D011135:Polysaccharides, Bacterial; D009848:Olivomycins
Vliianie olimitsina i bruneomitsina pri ovmestnom primenenii ikh s prodigiozanom na nekotorie nespetsificheskie zashchitnye REAKTSII ORGANIZMA S PRIVITYM LIMFADENOZOM NK-LI.